CORRECTING and REPLACING Former Apple CEO John Sculley Bets on eternalHealth, a Medicare Health Plan in Boston, and Joins as the Chairman of the Board

https://ift.tt/hOk5IKF

Business Wire India

CORRECTION...by eternalHealth

Please replace the release dated December 29, 2022 with the following corrected version due to multiple revisions to the second paragraph.

 

The release reads:

 

FORMER APPLE CEO JOHN SCULLEY BETS ON ETERNALHEALTH, A MEDICARE HEALTH PLAN IN BOSTON, AND JOINS AS THE CHAIRMAN OF THE BOARD

 

eternalHealth, the first Medicare Advantage Health Plan to get licensed in Massachusetts in nearly a decade, is looking to disrupt the health insurance industry by providing high quality, affordable care to Beneficiaries in Massachusetts and eventually beyond. The company also announced that former Apple CEO John Sculley has joined the firm as Chairman of its Board of Directors.

 

“Led by eternalHealth Founder and CEO Pooja Ika, a 25-year-old Babson graduate, the company has a simple mission of leverage technology to reduce health plan operating costs, allowing more dollars to be allocated towards patient care and benefits while embracing value-based care. This in turn will make healthcare more accountable, accessible, and comprehensive,” said Mr. Sculley, who as of December 1^st joined as Chairman of the eternalHealth board.

 

“I reinvented myself in healthcare after my time at Apple two decades ago, by investing and mentoring dozens of entrepreneurs within the healthcare industry; working with software, biotech, analytics, and services companies,” said Mr. Sculley. “When Pooja shared the vision behind eternalHealth and articulated that her beliefs were similar to mine, I knew that this was a company I was excited to be a part of. I look forward to working with Pooja, management, and a knowledgeable board to help grow the company.”

 

Mr. Sculley said that Americans spend $4 trillion on healthcare and a trillion of those dollars are wasted every year.

 

“All Payers (Commercial payers, State MEDICAID, and MEDICARE) pretty much manage the $4 trillion healthcare spend by deciding how care is delivered, measured, and paid for,” said Mr. Sculley. “I believe if payers deploy digital workplace automation for most of the transactions across their organization, they can substantially reduce administrative costs and leave more dollars for the total cost of care, allocating more towards providing quality care through a high-touch model to assist patients and physician partners. Secondly, there is so much potential to take value-based care to the next level through platform driven intelligence into physicians’ and hospitals’ existing workflows and empowering every care touch point with 360-degree view of the patients care history, creating opportunities to improve quality and reduce costs.”

 

eternalHealth strives to provide Medicare Beneficiaries with high-quality, affordable benefits that are comprehensive. By leveraging nirvanaHealth’s cloud-based technology platform, one that embraces artificial intelligence and robotic process automation, the organization can eliminate the cost and need to work with multiple different vendors and is able to automate close to 2,000-3,000 different transactional functions to operate as a compliant payer. These efficiencies allow eternalHealth to focus on the things that truly matter, such as working on providing enriched benefits at a lower cost to its members and removing the mistrust that exists between providers and payers by allocating more dollars towards the total cost of care and provider incentives. Additionally, the company will place a large emphasis on the member experience by rolling our various member focused initiatives to increase member satisfaction, retention, and help build a sense of community and belonging.

 

Ika states, “I could not be more honored to have someone like John chair our Board. He is a great addition to an already incredibly knowledgeable and strong board we have been fortunate to build. I am so excited to be able to tap into John’s decades of experience in consumerism. Medicare Marketing is extremely consumer focused and I look forward to bringing a fresh, new perspective to health insurance, one that is focused on John and I’s shared vision of bringing luxury to healthcare, without the luxury costs.”

 

About eternalHealth: Headquartered in Boston, eternalHealth provides high-quality care with low out-of-pocket costs to the residents of Massachusetts. eternalHealth is committed to placing the member at the forefront of every decision they make as an organization. Women-run, built, and owned, eternalHealth is a Medicare Advantage health plan that offers HMO and PPO products in three Massachusetts counties: Worcester, Middlesex, and Suffolk. For more information about eternalHealth’s plans and services, please visit www.eternalHealth.com.

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20221229005188/en/

VIDA, Powered by Hero, Commences Customer Deliveries

https://ift.tt/A8Fh0Yy

Business Wire India
VIDA, Powered by Hero, the emerging mobility brand of Hero MotoCorp, the world’s largest manufacturer of motorcycles and scooters, commenced customer deliveries of its electric vehicle - the VIDA V1 scooter - today.
 
Dr. Pawan Munjal, Chairman and CEO, Hero MotoCorp delivered the very first electric vehicle of the brand in Bengaluru, from VIDA’s Experience Center on Vittal Mallya Road.
 
Dr. Pawan Munjal, Chairman and CEO, Hero MotoCorp, said: “VIDA means life and today is giant leap forward in our lives. Our vision with VIDA is to establish future oriented mobility trends that will benefit the customers as well as the planet. With the commencement of customer deliveries, we are beginning to realize our vision. Everything in the VIDA World is developed with sustainability at its heart and with a technology-first philosophy that uplifts the customer experience. I invite everyone to experience the ‘Worry-free EV ecosystem’ of VIDA and the industry-leading features & performance of the VIDA V1.”
 
VIDA has Experience Centers in Bengaluru and Jaipur, and pop-up stores in Delhi-NCR, where customers can test-ride the Vida V1. Deliveries in Jaipur and Delhi will follow.
 
The highly customizable, Built-to-Last VIDA V1, with convenient removable batteries and three-way charging options, is available in two variants – VIDA V1 Plus at Rs. 135,705/- and VIDA V1 Pro at Rs. 146,880/-, price includes all connected features, portable charger and charging service.
(Effective On-Road Price Delhi)
 
The VIDA V1 comes with a best-in-class combination of performance (0-40 in 3.2 secs), a no compromise range (163 kms, IDC) and a top-speed of 80 km/h.
 
Dr. Swadesh Srivastava, Head – Emerging Mobility Business Unit (EMBU), Hero MotoCorp, said: “We are delighted to initiate customer deliveries of the VIDA V1. The deliveries are beginning from Bengaluru and will commence in other cities in a phased manner, just like the roll-out of the physical assets of our omnichannel approach. The ‘Worry-free EV ecosystem’ of VIDA is available in Bengaluru, Delhi-NCR and Jaipur, making EV ownership and usership simple and worry-free for customers here. Our tech-stack and physical assets are built to uplift the customer experience.”
 
The VIDA V1 also offers industry-leading features such as Custom Mode (100+ combinations), Cruise Control, Boost Mode, Two-way throttle, Key-less access and an Over-the-air enabled 7” TFT Touch-Screen. The VIDA V1 is based on an intelligent platform that’s modular, scalable & flexible, enabling it to learn and adapt on-the-go. The VIDA V1 evolves with the rider.
 
Reinforcing the brand’s Tech-First approach, the innovative and exciting Experience Centers provide an immersive and a completely differentiated experience to customers. Here customers are able to familiarize themselves with the brand, experience the product and immerse themselves in the “Worry-free EV Ecosystem” of VIDA.

Bringing a fresh approach to the category, VIDA offers first-of-its-kind customer propositions and services, that include Green EMI, an efficient and seamless financing platform with best-in-class interest rates. Buy-Back scheme with a first-in-industry assurance of vehicle buy-back at 70% of purchase value between the 16^th to 18^th months of vehicle ownership. Test-ride for up to three days, so customers can have peace of mind before purchasing the vehicle. VIDA also offers another industry-first initiative – Repair On-Site – with customer executives available to provide service anywhere, anytime.

Extramarks - The Teaching App Bags Two Awards for Its ASO Strategy

https://ift.tt/A8Fh0Yy

Business Wire India

Extramarks, one of India’s leading EdTech companies, has bagged industry honours for its App Store Optimization campaign for the Teaching App. The award-winning campaign improved the app ranking to 74 in the education category and a 759% improvement in App installs within six months. 

The App Store Optimization (ASO) campaign won a) Best Digital Strategy in the educational enterprise category at Digital Dragon Awards and Summit 2022 and b) Best New-age campaign (SEO) at DMAasia Sparkies Awards 2022 - organized by Indian Business Council.
 
The campaign objective was to increase the organic visibility of the Teaching App on the Google Play Store and App Store. Leveraging the experience and expertise of Infidigit, a customized ASO strategy resulted in a 926% increase in store listing visitors, and 25+ non-brand keywords ranking in the top 10 positions for Google Play Store.

“Extramarks-The Teaching App was launched earlier this year as a part of our efforts to ease the lives of teachers by supporting them with their tasks. The team optimized for multiple ASO parameters like app titles, screens, short and long descriptions, etc. to rank for important non-brand keywords in the Google Play Store. These optimizations resulted in the App reaching a significant position on the Google Play Store in six months, leading to improved visibility and increased installs. These awards give us confidence that the teachers are finding value in what the App offers. We will continue bringing innovations to the product to help educators progress through the digital era,” said Arpit Agarwal, Vice-president - Marketing, Extramarks Education.
 
Extramarks -The Teaching App is a one-stop solution for effortless teaching. It offers a robust assessment platform, extensive content repository, live class platform, and digital classroom management tools for home tutors, coaching centres, and schools. They can get started for free and take their first step towards digitization.
 
The company aims to build a community of teachers, home tutors, and educators through the Teaching App. The app can be downloaded from the Play Store or App Store.

Extramarks - The Teaching App Bags Two Awards for Its ASO Strategy

https://ift.tt/A8Fh0Yy

Business Wire India

Extramarks, one of India’s leading EdTech companies, has bagged industry honours for its App Store Optimization campaign for the Teaching App. The award-winning campaign improved the app ranking to 74 in the education category and a 759% improvement in App installs within six months. 

The App Store Optimization (ASO) campaign won a) Best Digital Strategy in the educational enterprise category at Digital Dragon Awards and Summit 2022 and b) Best New-age campaign (SEO) at DMAasia Sparkies Awards 2022 - organized by Indian Business Council.
 
The campaign objective was to increase the organic visibility of the Teaching App on the Google Play Store and App Store. Leveraging the experience and expertise of Infidigit, a customized ASO strategy resulted in a 926% increase in store listing visitors, and 25+ non-brand keywords ranking in the top 10 positions for Google Play Store.

“Extramarks-The Teaching App was launched earlier this year as a part of our efforts to ease the lives of teachers by supporting them with their tasks. The team optimized for multiple ASO parameters like app titles, screens, short and long descriptions, etc. to rank for important non-brand keywords in the Google Play Store. These optimizations resulted in the App reaching a significant position on the Google Play Store in six months, leading to improved visibility and increased installs. These awards give us confidence that the teachers are finding value in what the App offers. We will continue bringing innovations to the product to help educators progress through the digital era,” said Arpit Agarwal, Vice-president - Marketing, Extramarks Education.
 
Extramarks -The Teaching App is a one-stop solution for effortless teaching. It offers a robust assessment platform, extensive content repository, live class platform, and digital classroom management tools for home tutors, coaching centres, and schools. They can get started for free and take their first step towards digitization.
 
The company aims to build a community of teachers, home tutors, and educators through the Teaching App. The app can be downloaded from the Play Store or App Store.

Biocytogen Launches RenNano™ Mouse, a Fully Human Heavy Chain Antibody Platform to Accelerate Nanobody Drug Discovery

https://ift.tt/aFmplgt

Business Wire India

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) today officially launched its fully human heavy chain antibody platform, RenNano™. RenNano™ is the third member of the RenMice™ family, joining RenMab™ and RenLite^®. Together, Biocytogen’s three RenMice™ platforms allow for the streamlined discovery and development of fully human monoclonal antibodies, bispecific/multispecific antibodies and single-domain antibodies (sdAbs, or nanobodies).

 

While humans and mice generate antibodies that require heavy and light chain pairing to be functional, camels and sharks generate heavy-chain-only antibodies (HCAb), meaning their variable domains (VHH or sdAb) can function without pairing with the light chain. Owing to their nanometer-level size and small molecular weight, sdAbs have superior permeability, thus can cross the blood-brain barrier and infiltrate solid tumor tissues. In addition, the longer CDR3 region enables sdAbs to detect the otherwise hidden epitopes of GPCRs and other challenging targets. Since sdAbs have a simple structure, they are ideal building blocks for assembling bispecific/multispecific antibodies and CAR cell therapies.

 

While nanobodies have its unique advantages, animals that naturally produce HCAbs, such as camels, are difficult to be widely used for the preparation of monoclonal antibodies because they are large, having a long breeding cycle and few offspring. Meanwhile, humanization is required to develop camelid antibody sequences into drugs, which further increases the complexity and time of drug development.

 

Therefore, Biocytogen developed RenNano™ mouse that was engineered to produce HCAbs by modifying the constant region of the fully human RenMab™ model. Compared with other existing HCAb platforms, the in situ replacement of the mouse genes with the complete human heavy chain variable genes makes the RenNano™ mouse one of the most comprehensive fully human antibody platforms in the world. SdAb sequences generated from RenNano™ mice have the highest possible diversity, and do not require antibody humanization, which saves time and cost, and reduces risk of failure during later stages of drug development. Additionally, compared with camelids or other natural HCAb-producing species, mice are easier to breed and immunize. Our in-house studies show that immunization of RenNano™ mice can generate HCAbs with diverse CDR3 sequences that recognize a variety of epitopes. These HCAbs can recognize antigens with nM-level affinity independent of light chains. Moreover, antibodies derived from RenNano™ mice are capable of exerting biological functions both in vitro and in vivo. They are highly hydrophilic and have favorable developability characteristics.

 

The successful development of the RenNano™ platform expands Biocytogen’s capabilities of antibody discovery and broadens the applications of our antibody library. We welcome global partners to realize the full potential of our RenMice™ platforms and derived antibodies and bring benefit to the patients.

 

About RenMice

 

RenMice™, i.e., RenMab™, RenLite^® and RenNano™ mice, which have proprietary intellectual property rights, were developed by Biocytogen over the course of 5 years using size-unlimited, precise chromosome engineering technology (SUPCE). RenMice™ is one of the top 3 fully human antibody mice made by in situ replacement technology globally. All RenMice™ members contain full human heavy chain VDJ loci replaced in situ. Regarding antibody κ light chains, RenMab™ mouse contains full human VJ loci replaced in situ and RenLite^® mouse contains a single human VJ locus replaced in situ. RenNano™ mouse has modified heavy chain constant regions to generate functional HCAbs.

 

RenMice™ can generate robust immune response and produce fully human antibodies with great diversity, specificity, affinity and druggability. Using RenMice™, Biocytogen has built 6 fully human antibody discovery platforms, covering various types of targets and modalities such as monoclonal antibody (RenMab™), bispecific antibody and bispecific ADC (RenLite^®), nanobody (RenNano™), TCR-mimic antibody for intracellular targets (HLA/RenMice, i.e., MHC humanized RenMice™), and antibody platform against GPCR and other challenging targets (RenMice™ knockouts).

 

RenMice™ has been recognized by top biopharmaceutical companies around the world, including Merck KGaA, Xencor, BeiGene, Innovent, etc.

 

About Biocytogen:

 

Biocytogen (HKEX: 02315) is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Using its proprietary RenMab™/RenLite^®/RenNano™ mice platforms for fully human monoclonal antibody, bispecific/multispecific antibody and nanobody development, Biocytogen has integrated its in vivo drug efficacy screening platforms and strong clinical development expertise to streamline the entire drug development process. Biocytogen is undertaking a large-scale project to develop first-in-class and/or best-in-class antibody drugs for more than 1000 targets, known as Project Integrum. This project has resulted in 28 drug co-development agreements and 16 RenMice™ licensing agreements with companies around the world, including several partnerships with multinational pharmaceutical companies (MNCs). Biocytogen's pipeline includes 12 core products, among which two products are in phase II multi-regional clinical trials and two products are in phase I. Headquartered in Beijing, Biocytogen has branches in Haimen Jiangsu, Shanghai, Boston, USA and Heidelberg, Germany. For more information, please visit http://en.biocytogen.com.cn.

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20221229005124/en/

Former Apple CEO John Sculley Bets on eternalHealth, a Medicare Health Plan in Boston, and Joins as the Chairman of the Board

https://ift.tt/tvB3EbN

Business Wire India

eternalHealth, the first Medicare Advantage Health Plan to get licensed in Massachusetts in nearly a decade, is looking to disrupt the health insurance industry by providing high quality, affordable care to Beneficiaries in Massachusetts and eventually beyond. The company also announced that former Apple CEO John Sculley has joined the firm as Chairman of its Board of Directors.

 

Led by eternalHealth Founder and CEO Pooja Ika, a 25-year-old Babson graduate, the company has a simple mission of leverage technology to reduce health plan operating costs, allowing more dollars to be allocated towards patient care and benefits while embracing value-based care, letting for healthcare to be more accountable, accessible, and comprehensive, said Mr. Sculley, who as of December 1^st, joined as Chairman of the eternalHealth board.

 

“I reinvented myself in healthcare after my time at Apple two decades ago, by investing and mentoring dozens of entrepreneurs within the healthcare industry; working with software, biotech, analytics, and services companies,” said Mr. Sculley. “When Pooja shared the vision behind eternalHealth and articulated that her beliefs were similar to mine, I knew that this was a company I was excited to be a part of. I look forward to working with Pooja, management, and a knowledgeable board to help grow the company.”

 

Mr. Sculley said that Americans spend $4 trillion on healthcare and a trillion of those dollars are wasted every year.

 

“All Payers (Commercial payers, State MEDICAID, and MEDICARE) pretty much manage the $4 trillion healthcare spend by deciding how care is delivered, measured, and paid for,” said Mr. Sculley. “I believe if payers deploy digital workplace automation for most of the transactions across their organization, they can substantially reduce administrative costs and leave more dollars for the total cost of care, allocating more towards providing quality care through a high-touch model to assist patients and physician partners. Secondly, there is so much potential to take value-based care to the next level through platform driven intelligence into physicians’ and hospitals’ existing workflows and empowering every care touch point with 360-degree view of the patients care history, creating opportunities to improve quality and reduce costs.”

 

eternalHealth strives to provide Medicare Beneficiaries with high-quality, affordable benefits that are comprehensive. By leveraging nirvanaHealth’s cloud-based technology platform, one that embraces artificial intelligence and robotic process automation, the organization can eliminate the cost and need to work with multiple different vendors and is able to automate close to 2,000-3,000 different transactional functions to operate as a compliant payer. These efficiencies allow eternalHealth to focus on the things that truly matter, such as working on providing enriched benefits at a lower cost to its members and removing the mistrust that exists between providers and payers by allocating more dollars towards the total cost of care and provider incentives. Additionally, the company will place a large emphasis on the member experience by rolling our various member focused initiatives to increase member satisfaction, retention, and help build a sense of community and belonging.

 

Ika states, “I could not be more honored to have someone like John chair our Board. He is a great addition to an already incredibly knowledgeable and strong board we have been fortunate to build. I am so excited to be able to tap into John’s decades of experience in consumerism. Medicare Marketing is extremely consumer focused and I look forward to bringing a fresh, new perspective to health insurance, one that is focused on John and I’s shared vision of bringing luxury to healthcare, without the luxury costs.”

 

About eternalHealth: Headquartered in Boston, eternalHealth provides high-quality care with low out-of-pocket costs to the residents of Massachusetts. eternalHealth is committed to placing the member at the forefront of every decision they make as an organization. Women-run, built, and owned, eternalHealth is a Medicare Advantage health plan that offers HMO and PPO products in three Massachusetts counties: Worcester, Middlesex, and Suffolk. For more information about eternalHealth’s plans and services, please visit www.eternalHealth.com.

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20221229005188/en/

BlackRock® Canada Announces Final Annual Reinvested Capital Gains Distributions for the iShares® ETFs

TORONTO, Dec. 29, 2022 (GLOBE NEWSWIRE) -- BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (NYSE: BLK), today announced the final annual reinvested capital gains distributions for the iShares ETFs listed on the TSX or NEO for the 2022 tax year.

The distributions are for the annual non-cash capital gains distributions, which are typically reinvested in additional units of the respective funds at the year-end, and do not include estimates of ongoing monthly, quarterly, semi-annual, or annual cash distribution amounts. The additional units will be immediately consolidated with the previously outstanding units such that the number of outstanding units following the distribution will equal the number of units outstanding prior to the distribution.

The record date for the 2022 annual distributions will be December 30, 2022, payable on January 5, 2023. The actual taxable amounts of reinvested and cash distributions for 2022, including the tax characteristics of the distributions, will be reported to brokers (through CDS Clearing and Depository Services Inc. or “CDS”) in early 2023.

Details regarding the “per unit” distribution amounts are as follows:

Fund Name	Fund Ticker	Reinvested Capital Gains Distribution Per Unit ($)
iShares 1-10 Year Laddered Corporate Bond Index ETF	CBH	0.00000
iShares 1-5 Year Laddered Corporate Bond Index ETF	CBO	0.00000
iShares S&P/TSX Canadian Dividend Aristocrats Index ETF	CDZ	2.33416
iShares Equal Weight Banc & Lifeco ETF	CEW	0.51311
iShares Gold Bullion ETF	CGL	0.00000
iShares Gold Bullion ETF	CGL.C	0.00000
iShares Global Real Estate Index ETF	CGR	0.00000
iShares U.S. High Yield Fixed Income Index ETF (CAD-Hedged)	CHB	0.00000
iShares International Fundamental Index ETF	CIE	0.39335
iShares Global Infrastructure Index ETF	CIF	1.07127
iShares Japan Fundamental Index ETF (CAD-Hedged)	CJP	1.11014
iShares 1-5 Year Laddered Government Bond Index ETF	CLF	0.00000
iShares 1-10 Year Laddered Government Bond Index ETF	CLG	0.00000
iShares US Fundamental Index ETF	CLU	0.25859
iShares US Fundamental Index ETF	CLU.C	0.00000
iShares Premium Money Market ETF(2)	CMR	0.00607
iShares Global Agriculture Index ETF	COW	3.49044
iShares S&P/TSX Canadian Preferred Share Index ETF	CPD	0.00000
iShares Canadian Fundamental Index ETF	CRQ	1.08406
iShares Short Duration High Income ETF (CAD-Hedged)	CSD	0.00000
iShares US Dividend Growers Index ETF (CAD-Hedged)	CUD	1.11286
iShares Convertible Bond Index ETF	CVD	0.00000
iShares Emerging Markets Fundamental Index ETF	CWO	0.41762
iShares Global Water Index ETF	CWW	0.00000
iShares Global Monthly Dividend Index ETF (CAD-Hedged)	CYH	0.00000
iShares Canadian Financial Monthly Income ETF	FIE	0.00000
iShares ESG Balanced ETF Portfolio	GBAL	0.00000
iShares ESG Conservative Balanced ETF Portfolio	GCNS	0.00000
iShares ESG Equity ETF Portfolio	GEQT	0.00000
iShares ESG Growth ETF Portfolio	GGRO	0.00000
iShares Silver Bullion ETF	SVR	0.00000
iShares Silver Bullion ETF	SVR.C	0.00000
iShares U.S. Aggregate Bond Index ETF	XAGG	0.00000
iShares U.S. Aggregate Bond Index ETF(1)	XAGG.U	0.00000
iShares U.S. Aggregate Bond Index ETF (CAD-Hedged)	XAGH	0.00000
iShares Core MSCI All Country World ex Canada Index ETF	XAW	0.32441
iShares Core MSCI All Country World ex Canada Index ETF(1)	XAW.U	0.24229
iShares Core Balanced ETF Portfolio	XBAL	0.19647
iShares Core Canadian Universe Bond Index ETF	XBB	0.00000
iShares S&P/TSX Global Base Metals Index ETF	XBM	0.41548
iShares Core Canadian Corporate Bond Index ETF	XCB	0.00000
iShares ESG Advanced Canadian Corporate Bond Index ETF	XCBG	0.00000
iShares U.S. IG Corporate Bond Index ETF	XCBU	0.00000
iShares U.S. IG Corporate Bond Index ETF(1)	XCBU.U	0.00000
iShares S&P Global Consumer Discretionary Index ETF (CAD-Hedged)	XCD	0.52250
iShares Canadian Growth Index ETF	XCG	0.70312
iShares China Index ETF	XCH	0.00000
iShares Global Clean Energy Index ETF	XCLN	0.00000
iShares ESG MSCI Canada Leaders Index ETF	XCLR	0.00000
iShares Core Conservative Balanced ETF Portfolio	XCNS	0.00000
iShares S&P/TSX SmallCap Index ETF	XCS	0.74131
iShares ESG Advanced MSCI Canada Index ETF	XCSR	0.20395
iShares Canadian Value Index ETF	XCV	1.17295
iShares Core MSCI Global Quality Dividend Index ETF	XDG	0.16111
iShares Core MSCI Global Quality Dividend Index ETF(1)	XDG.U	0.12231
iShares Core MSCI Global Quality Dividend Index ETF (CAD-Hedged)	XDGH	0.00000
iShares Core MSCI Canadian Quality Dividend Index ETF	XDIV	1.20507
iShares ESG MSCI EAFE Leaders Index ETF(2)	XDLR	0.50000
iShares Genomics Immunology and Healthcare Index ETF	XDNA	0.00000
iShares ESG Advanced MSCI EAFE Index ETF	XDSR	0.00000
iShares Core MSCI US Quality Dividend Index ETF	XDU	0.86110
iShares Core MSCI US Quality Dividend Index ETF(1)	XDU.U	0.63781
iShares Core MSCI US Quality Dividend Index ETF (CAD-Hedged)	XDUH	0.00000
iShares Canadian Select Dividend Index ETF	XDV	1.07061
iShares J.P. Morgan USD Emerging Markets Bond Index ETF (CAD-Hedged)	XEB	0.00000
iShares Core MSCI Emerging Markets IMI Index ETF	XEC	0.00000
iShares Core MSCI Emerging Markets IMI Index ETF(1)	XEC.U	0.00000
iShares Core MSCI EAFE IMI Index ETF	XEF	0.22417
iShares Core MSCI EAFE IMI Index ETF(1)	XEF.U	0.14339
iShares S&P/TSX Capped Energy Index ETF	XEG	0.22112
iShares MSCI Europe IMI Index ETF (CAD-Hedged)	XEH	0.63026
iShares S&P/TSX Composite High Dividend Index ETF	XEI	1.93810
iShares MSCI Emerging Markets Index ETF	XEM	0.00000
iShares Jantzi Social Index ETF	XEN	0.00000
iShares Core Equity ETF Portfolio	XEQT	0.29106
iShares ESG Aware MSCI Canada Index ETF	XESG	0.21706
iShares MSCI Europe IMI Index ETF	XEU	0.00000
iShares Exponential Technologies Index ETF(2)	XEXP	0.94119
iShares MSCI Multifactor USA Index ETF (CAD-Hedged)	XFA	0.00000
iShares MSCI Multifactor Canada Index ETF	XFC	0.00000
iShares MSCI Multifactor EAFE Index ETF (CAD-Hedged)	XFF	0.00000
iShares Core MSCI EAFE IMI Index ETF (CAD-Hedged)	XFH	1.95637
iShares MSCI Multifactor EAFE Index ETF	XFI	0.00000
iShares S&P/TSX Capped Financials Index ETF	XFN	2.19994
iShares Floating Rate Index ETF	XFR	0.00000
iShares MSCI Multifactor USA Index ETF	XFS	1.47999
iShares MSCI Multifactor USA Index ETF(1)	XFS.U	1.09411
iShares Core Canadian Government Bond Index ETF	XGB	0.00000
iShares S&P/TSX Global Gold Index ETF	XGD	0.00000
iShares Global Government Bond Index ETF (CAD-Hedged)	XGGB	0.00000
iShares S&P Global Industrials Index ETF (CAD-Hedged)	XGI	0.00000
iShares Core Growth ETF Portfolio	XGRO	0.29890
iShares Cybersecurity and Tech Index ETF(2)	XHAK	0.24323
iShares Canadian HYBrid Corporate Bond Index ETF	XHB	0.00000
iShares Global Healthcare Index ETF (CAD-Hedged)	XHC	0.00000
iShares U.S. High Dividend Equity Index ETF (CAD-Hedged)	XHD	0.00000
iShares U.S. High Dividend Equity Index ETF	XHU	0.00000
iShares U.S. High Yield Bond Index ETF (CAD-Hedged)	XHY	0.00000
iShares Core S&P/TSX Capped Composite Index ETF	XIC	1.07857
iShares India Index ETF	XID	1.29284
iShares U.S. IG Corporate Bond Index ETF (CAD-Hedged)	XIG	0.00000
iShares 1-5 Year U.S. IG Corporate Bond Index ETF (CAD-Hedged)	XIGS	0.00000
iShares MSCI EAFE® Index ETF (CAD-Hedged)	XIN	2.26095
iShares Core Income Balanced ETF Portfolio	XINC	0.00000
iShares S&P/TSX Capped Information Technology Index ETF	XIT	0.00000
iShares S&P/TSX 60 Index ETF	XIU	0.00000
iShares Core Canadian Long Term Bond Index ETF	XLB	0.00000
iShares S&P/TSX Capped Materials Index ETF	XMA	0.00000
iShares S&P U.S. Mid-Cap Index ETF	XMC	0.13855
iShares S&P U.S. Mid-Cap Index ETF(1)	XMC.U	0.10333
iShares S&P/TSX Completion Index ETF	XMD	0.99515
iShares S&P U.S. Mid-Cap Index ETF (CAD-Hedged)	XMH	0.00000
iShares MSCI Min Vol EAFE Index ETF	XMI	0.00000
iShares MSCI Min Vol EAFE Index ETF (CAD-Hedged)	XML	0.00000
iShares MSCI Min Vol Emerging Markets Index ETF	XMM	0.00000
iShares MSCI Min Vol USA Index ETF (CAD-Hedged)	XMS	0.00000
iShares MSCI USA Momentum Factor Index ETF	XMTM	0.00000
iShares MSCI Min Vol USA Index ETF	XMU	0.00000
iShares MSCI Min Vol USA Index ETF(1)	XMU.U	0.00000
iShares MSCI Min Vol Canada Index ETF	XMV	0.85190
iShares MSCI Min Vol Global Index ETF	XMW	0.23619
iShares MSCI Min Vol Global Index ETF (CAD-Hedged)	XMY	0.18378
iShares S&P/TSX North American Preferred Stock Index ETF (CAD-Hedged)	XPF	0.00000
iShares High Quality Canadian Bond Index ETF	XQB	0.00000
iShares MSCI USA Quality Factor Index ETF	XQLT	0.00000
iShares NASDAQ 100 Index ETF (CAD-Hedged)	XQQ	0.39216
iShares Canadian Real Return Bond Index ETF(2)	XRB	1.67194
iShares S&P/TSX Capped REIT Index ETF	XRE	0.09172
iShares ESG Aware Canadian Aggregate Bond Index ETF	XSAB	0.00000
iShares Core Canadian Short Term Bond Index ETF	XSB	0.00000
iShares Conservative Short Term Strategic Fixed Income ETF	XSC	0.00000
iShares Conservative Strategic Fixed Income ETF	XSE	0.00000
iShares ESG Aware MSCI EAFE Index ETF	XSEA	0.00000
iShares ESG Aware MSCI Emerging Markets Index ETF	XSEM	0.00000
iShares Core Canadian Short Term Corporate Bond Index ETF	XSH	0.00000
iShares ESG Advanced 1-5 Year Canadian Corporate Bond Index ETF	XSHG	0.00000
iShares 1-5 Year U.S. IG Corporate Bond Index ETF	XSHU	0.00000
iShares 1-5 Year U.S. IG Corporate Bond Index ETF(1)	XSHU.U	0.00000
iShares Short Term Strategic Fixed Income ETF	XSI	0.00000
iShares S&P U.S. Small-Cap Index ETF	XSMC	0.00000
iShares S&P U.S. Small-Cap Index ETF (CAD-Hedged)	XSMH	0.00000
iShares Core S&P 500 Index ETF (CAD-Hedged)	XSP	0.00000
iShares Short Term High Quality Canadian Bond Index ETF	XSQ	0.00000
iShares S&P/TSX Capped Consumer Staples Index ETF	XST	0.93593
iShares ESG Aware Canadian Short Term Bond Index ETF	XSTB	0.00000
iShares 0-5 Year TIPS Bond Index ETF (CAD-Hedged)	XSTH	0.00000
iShares 0-5 Year TIPS Bond Index ETF	XSTP	0.00000
iShares 0-5 Year TIPS Bond Index ETF(1)	XSTP.U	0.00000
iShares U.S. Small Cap Index ETF (CAD-Hedged)	XSU	0.00000
iShares ESG Aware MSCI USA Index ETF	XSUS	0.00000
iShares Diversified Monthly Income ETF	XTR	0.00000
iShares Core S&P U.S. Total Market Index ETF (CAD-Hedged)	XUH	0.00000
iShares ESG MSCI USA Leaders Index ETF	XULR	0.00000
iShares Core S&P 500 Index ETF	XUS	0.94421
iShares Core S&P 500 Index ETF(1)	XUS.U	0.69707
iShares ESG Advanced MSCI USA Index ETF	XUSR	0.00000
iShares S&P/TSX Capped Utilities Index ETF	XUT	0.30938
iShares Core S&P U.S. Total Market Index ETF	XUU	0.32554
iShares Core S&P U.S. Total Market Index ETF(1)	XUU.U	0.23667
iShares MSCI USA Value Factor Index ETF	XVLU	0.00000
iShares MSCI World Index ETF	XWD	0.92519

⁽¹⁾ Distribution per unit amounts are in U.S. dollars for XAGG.U, XAW.U, XCBU.U, XDG.U, XDU.U, XEC.U, XEF.U, XFS.U, XMC.U, XMU.U, XSHU.U, XSTP.U, XUS.U, and XUU.U.

⁽²⁾ For iShares Premium Money Market ETF (CMR), iShares ESG MSCI EAFE Leaders Index ETF (XDLR), iShares Exponential Technologies Index ETF (XEXP), iShares Cybersecurity and Tech Index ETF (XHAK), iShares Canadian Real Return Bond Index ETF (XRB) only, the distribution amount may include an income component.

Further information on the iShares ETFs can be found at http://www.blackrock.com/ca.

About BlackRock
BlackRock’s purpose is to help more and more people experience financial well-being. As a fiduciary to investors and a leading provider of financial technology, we help millions of people build savings that serve them throughout their lives by making investing easier and more affordable. For additional information on BlackRock, please visit www.blackrock.com/corporate | Twitter: @BlackRockCA

About iShares
iShares unlocks opportunity across markets to meet the evolving needs of investors. With more than twenty years of experience, a global line-up of 900+ exchange traded funds (ETFs) and US$2.62 trillion in assets under management as of September 30, 2022, iShares continues to drive progress for the financial industry. iShares funds are powered by the expert portfolio and risk management of BlackRock.

iShares ETFs are managed by BlackRock Asset Management Canada Limited.

Commissions, trailing commissions, management fees and expenses all may be associated with investing in iShares ETFs. Please read the relevant prospectus before investing. The funds are not guaranteed, their values change frequently and past performance may not be repeated. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional.

Standard & Poor’s® and S&P® are registered trademarks of Standard & Poor’s Financial Services LLC (“S&P”). Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC (“Dow Jones”). TSX is a registered trademark of TSX Inc. (“TSX”). All of the foregoing trademarks have been licensed to S&P Dow Jones Indices LLC and sublicensed for certain purposes to BlackRock Fund Advisors (“BFA”), which in turn has sub-licensed these marks to its affiliate, BlackRock Asset Management Canada Limited (“BlackRock Canada”), on behalf of the applicable fund(s). The index is a product of S&P Dow Jones Indices LLC, and has been licensed for use by BFA and by extension, BlackRock Canada and the applicable fund(s). The funds are not sponsored, endorsed, sold or promoted by S&P Dow Jones Indices LLC, Dow Jones, S&P, any of their respective affiliates (collectively known as “S&P Dow Jones Indices”) or TSX, or any of their respective affiliates. Neither S&P Dow Jones Indices nor TSX make any representations regarding the advisability of investing in such funds.

MSCI is a trademark of MSCI, Inc. (“MSCI”). The ETF is permitted to use the MSCI mark pursuant to a license agreement between MSCI and BlackRock Institutional Trust Company, N.A., relating to, among other things, the license granted to BlackRock Institutional Trust Company, N.A. to use the Index. BlackRock Institutional Trust Company, N.A. has sublicensed the use of this trademark to BlackRock. The ETF is not sponsored, endorsed, sold or promoted by MSCI and MSCI makes no representation, condition or warranty regarding the advisability of investing in the ETF.

Contact for Media:
Reem Jazar
Email: reem.abujazar@blackrock.com

Via GlobeNewswire RSS Feed https://ift.tt/kXuKC2Y